Jennison Associates’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-59,408
| Closed | -$790K | – | 594 |
|
|
2023
Q2 | $790K | Sell |
59,408
-17,580
| -23% | -$234K | ﹤0.01% | 512 |
|
|
2023
Q1 | $892K | Sell |
76,988
-1,700
| -2% | -$19.7K | ﹤0.01% | 507 |
|
|
2022
Q4 | $644K | Sell |
78,688
-98,604
| -56% | -$807K | ﹤0.01% | 544 |
|
|
2022
Q3 | $1.03M | Buy |
177,292
+24,127
| +16% | +$140K | ﹤0.01% | 504 |
|
|
2022
Q2 | $677K | Buy |
153,165
+70,949
| +86% | +$314K | ﹤0.01% | 567 |
|
|
2022
Q1 | $748K | Buy |
+82,216
| New | +$748K | ﹤0.01% | 597 |
|